A2385

5-Azacytidine

≥98% (HPLC), powder, DNA methyltransferase inhibitor

• Sinónimos: 5-Azacitidine, 4-Amino-1-(β-D-ribofuranosyl)-1,3,5-triazin-2(1H)-one, Ladakamycin
• Fórmula empírica (notación de Hill): C₈H₁₂N₄O₅
• Número de CAS: 320-67-2
• Peso molecular: 244.20
• Beilstein/REAXYS Number: 620461
• EC Number: 206-280-2
• MDL number: MFCD00006539
• UNSPSC Code: 12352200
• PubChem Substance ID: 24278211
• NACRES: NA.77

Propiedades

• Nombre del producto: 5-Azacytidine, ≥98% (HPLC)
• Quality Level: 200
• assay: ≥98% (HPLC)
• form: powder
• mp: 226-232 °C (dec.) (lit.)
• antibiotic activity spectrum: viruses
• mode of action: DNA synthesis | interferes
• originator: Celgene
• storage temp.: −20°C
• SMILES string: NC1=NC(=O)N(C=N1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O
• InChI: 1S/C8H12N4O5/c9-7-10-2-12(8(16)11-7)6-5(15)4(14)3(1-13)17-6/h2-6,13-15H,1H2,(H2,9,11,16)/t3-,4-,5-,6-/m1/s1
• InChI key: NMUSYJAQQFHJEW-KVTDHHQDSA-N
• Gene Information: human ... DNMT1(1786) , DNMT3A(1788) , DNMT3B(1789)

Descripción

General description

5-Azacytidine is a chemical analog of cytidine. It functions as a hypomethylating agent. 5-Azacytidine is used to treat myelodysplastic syndrome (MDS).

Chemical structure: nucleoside

Application

5-Azacytidine has been used:

• for cell induction
• to study its effects on bovine fetal mesenchymal stem cells (bfMSC)
• to study its effects on human bone marrow stromal cells (hBMSCs)
• to study its effects on and DNA methyltransferase 1 (DNMT1) and Ras protein activator like 1 (RASAL1) expression
• to interfere with DNA methylation and histone acetylation
• to determine its effects on the conversion of control fibroblasts
• for optical coherence tomography (OCT) and fluorescein angiography (FA)
• for the reactivation of Sal-like protein (SALL)3 expression

Biochem/physiol Actions

5-Azacytidine (Aza-CR) acts as a potential chemotherapeutic regimen for acute myelogenous leukemia. This drug has an ability to selectively increase γ-globin synthesis. Therefore, 5-azacytidine is used in treating severe β-thalassemia. Aza-CR acts as a potential bacteriostatic, antitumor and mutagenic agent. In addition, it also exhibits various biological activity such as, immunosuppressive, antimitotic, radioprotective and virostatic effects.

A potent growth inhibitor and cytotoxic agent; inhibits DNA methyltransferase, an important regulatory mechanism of gene expression, gene activation and silencing.

Causes DNA demethylation or hemi-demethylation, creating openings that allow transcription factors to bind to DNA and reactivate tumor suppressor genes.

Potent growth inhibitor and cytotoxic agent; inhibits DNA methyltransferase.

Features and Benefits

This compound is a featured product for Gene Regulation research. Click here to discover more featured Gene Regulation products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm.

This compound was developed by Celgene. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Información de seguridad

• pictograms: GHS08,GHS07,GHS09
• signalword: Danger
• hcodes: H302,H341,H350,H360FD,H372,H410
• pcodes: P202 - P260 - P264 - P273 - P301 + P312 - P308 + P313
• Hazard Classifications: Acute Tox. 4 Oral - Aquatic Chronic 1 - Carc. 1A - Muta. 2 - Repr. 1B - STOT RE 1
• Storage Class: 6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
• wgk_germany: WGK 3
• ppe: Eyeshields, Gloves, type P3 (EN 143) respirator cartridges